Per a court order, HHS is required to restore this website to its version as of 12:00 AM on January 29, 2025. Information on this page may be modified and/or removed in the future subject to the terms of the court’s order and implemented consistent with applicable law. Any information on this page promoting gender ideology is extremely inaccurate and disconnected from truth. The Trump Administration rejects gender ideology due to the harms and divisiveness it causes. This page does not reflect reality and therefore the Administration and this Department reject it.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Increase aspirin use for secondary prevention of atherosclerotic cardiovascular disease — HDS‑08

Status: Little or no detectable change

  
Little or no detectable change
Learn more about our data release schedule

Most Recent Data:
69.0 percent (2017-20) *

Target:
69.4 percent 1  *

Desired Direction:
Increase desired

Baseline:
63.5 percent of adults aged 40 years and over with a history of cardiovascular disease were using aspirin in 2013-16 2 *

*  Age adjusted to the year 2000 standard population.

See detailed data for this objective

Increase the proportion of adults with a history of cardiovascular disease who are using aspirin therapy to prevent recurrent cardiovascular events

Target-Setting Method
Minimal statistical significance

Data Source:  National Health and Nutrition Examination Survey (NHANES), CDC/NCHS

Learn more about data measurement for this objective

Summary

Heart disease is the leading cause of death in the United States, and stroke is the fifth leading cause. People who have had ischemic heart disease or ischemic stroke can lower their risk of future recurring heart problems or stroke by taking aspirin every day.

Topics:  Heart Disease and Stroke, Health Care, Preventive Care

Workgroup: Heart Disease and Stroke Workgroup

Other objectives you may be interested in

Browse all Healthy People 2030 objectives

1. Target has been revised. See Data Methodology and Measurement for more information.

2. Baseline has been revised. See Data Methodology and Measurement for more information.